These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18262049)

  • 21. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.
    Wikman H; Nymark P; Väyrynen A; Jarmalaite S; Kallioniemi A; Salmenkivi K; Vainio-Siukola K; Husgafvel-Pursiainen K; Knuutila S; Wolf M; Anttila S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):193-9. PubMed ID: 15543620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
    Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
    Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERBB2 amplifications in esophageal adenocarcinoma.
    Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
    Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
    Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overrepresentation of 8q in carcinosarcomas and endometrial adenocarcinomas.
    Schulten HJ; Gunawan B; Enders C; Donhuijsen K; Emons G; Füzesi L
    Am J Clin Pathol; 2004 Oct; 122(4):546-51. PubMed ID: 15487452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
    Tanner MM; Karhu RA; Nupponen NN; Borg A; Baldetorp B; Pejovic T; Fernö M; Killander D; Isola JJ
    Am J Pathol; 1998 Jul; 153(1):191-9. PubMed ID: 9665480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
    Riben MW; Malfetano JH; Nazeer T; Muraca PJ; Ambros RA; Ross JS
    Mod Pathol; 1997 Aug; 10(8):823-31. PubMed ID: 9267826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of chromosomal aberrations involving chromosome 1q31-->q53 in a DMBA-induced rat fibrosarcoma cell line: amplification and overexpression of Jak2.
    Sjöling A; Lindholm H; Samuelson E; Yamasaki Y; Watanabe TK; Tanigami A; Levan G
    Cytogenet Cell Genet; 2001; 95(3-4):202-9. PubMed ID: 12063401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of chromosomal abnormalities in gastric adenocarcinomas.
    Wu CW; Chen GD; Fann CS; Lee AF; Chi CW; Liu JM; Weier U; Chen JY
    Genes Chromosomes Cancer; 2002 Nov; 35(3):219-31. PubMed ID: 12353264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide aberrations in pancreatic adenocarcinoma.
    Nowak NJ; Gaile D; Conroy JM; McQuaid D; Cowell J; Carter R; Goggins MG; Hruban RH; Maitra A
    Cancer Genet Cytogenet; 2005 Aug; 161(1):36-50. PubMed ID: 16080956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
    Tsuji K; Yasui K; Gen Y; Endo M; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Apr; 198(2):118-25. PubMed ID: 20362226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hgfr/Met oncogene acts as target for gene amplification in DMBA-induced rat sarcomas: free chromatin fluorescence in situ hybridization analysis of amplicon arrays in homogeneously staining regions.
    Helou K; Walentinsson A; Kost-Alimova M; Levan G
    Genes Chromosomes Cancer; 2001 Apr; 30(4):416-20. PubMed ID: 11241796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon.
    Shinomiya T; Mori T; Ariyama Y; Sakabe T; Fukuda Y; Murakami Y; Nakamura Y; Inazawa J
    Genes Chromosomes Cancer; 1999 Apr; 24(4):337-44. PubMed ID: 10092132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.